Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03766152
Other study ID # 1757/2018
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date November 1, 2018
Est. completion date December 13, 2019

Study information

Verified date December 2019
Source Medical University of Vienna
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Patients implanted with a Bonebridge will be asked to be part of the study. The study subjects are enrolled into the study according to inclusion criteria.

Patients will be asked to wear an adhesive bone conduction device an adapt to it for 30-60 min. After this time period patients will be asked to use the adhesive device instead of the Bonebridge for 3 weeks. Audiologic Tests and quality of life questionnaires will be assessed at the beginning of the study and at the end of three weeks.


Description:

Phase 1 Patients will be fitted with an adhesive bone conduction device and asked to fill out two questionnaires. They will then wear the device for 30-60 minutes and decide if they want to wear the device for the remaining study time of three weeks. Patients who do not have sufficient benefit from the device or do not feel comfortable with it do not enter the second study period of wearing the device for three weeks. Patients will be asked to comment on their experiences after 30 to 60 minutes explaining why they do not want to enter the second part of the study if they feel comfortable sharing this information. Phase 2 Patients, in the second study period, will be asked to wear the hearing device as long as comfortable to them every day and mark time of device usage, battery life, changes of the adhesive adapter, sound quality and comfort related remarks in a diary. After three weeks patients will return to the outpatient ́s department for an audiological assessment and a second set of quality of hearing and quality of life questionnaire.

No patients will be implanted with a Bonebridge as part of the study.

Audiologic testing consists of sound field audiometry, Freiburg monosyllables test and Oldenburg sentence test.

Questionnaires consist of the AQol-8D and the SSQ-12


Recruitment information / eligibility

Status Completed
Enrollment 19
Est. completion date December 13, 2019
Est. primary completion date October 31, 2019
Accepts healthy volunteers No
Gender All
Age group 13 Years to 99 Years
Eligibility Inclusion Criteria:

- Patients implanted with a Bonebridge device and are active users

- Unilateral and/or bilateral conductive hearing loss (CHL)

- Subjects aged 13 years or older

- Capable of the German language

- Willingness and ability to perform all tests required for the study

- Signed, and dated informed consent before the start of any study specific procedure

Exclusion Criteria:

- Pregnancy or breastfeeding

- Patient is intolerant of the materials as described by Manufacturer's IFU

- Patient presents with a skin or scalp condition that may preclude the attachment of the adhesive adapter.

- Patient cannot perform the audiological tests or is unable to fill out the questionnaires.

- Patient presents with retrocochlear, or central auditory disorder.

- any physical, psychological, or emotional disorder that would interfere with the ability to perform on test and rehabilitation procedures

Study Design


Intervention

Device:
Adhesive bone conduction hearing aid (ADHEAR - Med El)
Patients are asked to wear an adhesive bone conduction hearing device which is attached to the mastoid with an adhesive adapter

Locations

Country Name City State
Austria MUW, AKH Vienna

Sponsors (1)

Lead Sponsor Collaborator
Dominik Riss

Country where clinical trial is conducted

Austria, 

Outcome

Type Measure Description Time frame Safety issue
Primary Average functional hearing gain The primary endpoint of the study is the average functional hearing gain evaluated by the free field audiometry (at 4 different frequencies) using the bone conduction device compared to the unaided situation. To compare the two hearing devices the following primary endpoint measure will be calculated: ?mean= {(Average functional hearing gain with Bonebridge - Average functional hearing gain with ADHEAR at timepoint T1 (=?1)) + (Average functional hearing gain with Bonebridge - Average functional hearing gain with ADHEAR at timepoint T2 (=?2))} divided by two. Measuring both hearing devices at both timepoints and using the mean difference (?mean) enables adjustment for a possible underlying customization effect. 3 weeks
Secondary AQoL-8D (quality of life) Will be measured by comparing Quality of Life as assessed with AQoL - 8D at the beginning of the study and the end of the study (The result of the AQoL-8D is a number) 3 weeks
Secondary Quality of hearing Quality of hearing as assessed with the SSQ 12 questionnaire will be compared at the beginning of the study to the results after the three weeks with the adhesive device.
The results of the SSQ-12 is a number
3 weeks
Secondary Word recognition score Further secondary outcomes will be assessed by comparing the results of the word recognition test in the aided condition once with the implanted device (Bonebridge) in comparison to the adhesive device (ADHEAR). Word recognition is measured in percent at two different noise levels 3 weeks
Secondary Sentence test Further secondary outcomes will be assessed by comparing the results of the sentence test in the aided condition once with the implanted device (Bonebridge) in comparison to the adhesive device (ADHEAR). Sentence test results are measured as percent at a certain volume level (dB). 3 weeks
See also
  Status Clinical Trial Phase
Completed NCT05086809 - Investigation of an Updated Bone-anchored Sound Processor N/A
Recruiting NCT05615649 - Expanded Indications in the Pediatric BONEBRIDGE Population N/A
Completed NCT04147611 - Remote Microphone (RM) - A Comparative Study N/A
Recruiting NCT06058767 - Preschool Hearing Screening N/A
Completed NCT03333577 - Evaluation of the Baha SoundArc in Pediatric Patients N/A
Active, not recruiting NCT03742089 - Evaluation of the BHX Implant in Children With a BAHS
Not yet recruiting NCT06338670 - Clinical Performance of the Osia 3 Sound Processor Compared With the Osia 2 Sound Processor in Adult Osia Implant Users N/A
Completed NCT01822119 - Clinical Performance of a Transcutaneous Bone Conduction Hearing Solution (Baha® Attract System) N/A
Recruiting NCT04803279 - Investigating Hearing With Ponto 3 SuperPower, a Bone Anchored Hearing Aid - Investigating Hear
Not yet recruiting NCT04427631 - Exploring Interventions for Glue Ear During Covid-19 N/A
Completed NCT02022085 - Post-market Clinical Follow-up of a Magnetic Bone Conduction Implant (Cochlear Baha Attract System) N/A
Completed NCT01738490 - Long-term Stability and Survival Rates of a Novel Oticon Medical Bone Conduction Device Implant N/A
Recruiting NCT05055115 - Ph.D.-Project: Eustachian Tube Dysfunction: Causes, Diagnosis, Treatment, and Prognosis N/A
Completed NCT03129191 - Audiological Benefit With Non-implantable Bone Conduction Hearing Systems N/A
Recruiting NCT04899037 - Pilot Study to Evaluate the Long-term Chronic Care of Patients Who Could or do Utilize an Osseointegrated Device (OID)
Completed NCT01858246 - A Randomised Controlled Trial Comparing Bone Anchored Hearing Aid With Bonebridge N/A
Active, not recruiting NCT05166265 - Clinical Investigation Study of Safety and Performance of the Sentio System. N/A
Completed NCT04761926 - Investigating Hearing With the Ponto 4, a Bone Anchored Hearing Aid N/A
Completed NCT01796236 - Clinical and Health Economic Evaluation With a New Baha® Abutment Combined With a Minimally Invasive Surgical Technique N/A
Completed NCT06256081 - Testing a New App for Children With Glue Ear N/A